Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations...more...
Aurobindo Pharma announced that its subsidiary Apitoria Pharma Pvt Ltd has received an Establishment Inspection Report (EIR) from the US FDA...more...
Aurobindo Pharma Limited has informed the Exchange about General Updatesmore...
Intimation of classification of Unit-V of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company as VAI by the US FDA.more...
Intimation of classification of Unit-II of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company as OAI by the US FDA.more...
Intimation of order received from GST authorities.more...
Aurobindo Pharma Limited on Thursday said that its wholly owned subsidiary has received an Establishment Inspection Report (EIR) with a Voluntary Act...more...
Intimation of classification of Unit-IV of APL Healthcare Limited a wholly owned subsidiary of the Company as VAI by the US FDA.more...
Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...
Intimation of plant visit by a group of investors on 17.03.2026.more...
Intimation of plant visit by investor group on 16.03.2026.more...
Intimation of investor meet to be held on 13.03.2026.more...
Eugia Pharma Specialities Limited a wholly owned subsidiary of Aurobindo Pharma Limited has announced the launch of Pomalidomide Capsules in...more...
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 04 2026 titled Eugia Pharma announces launch of Pomalidomide...more...
Submission of press release on launch of Pomalidomide Capsules 1 mg 2 mg 3 mg and 4 mg in the US market by Eugia Pharma Specialities LImited...more...
BOARD MEETINGS Company Name : Jash Engineering Date : 30-03-2026